The discovery in the lab of Duke cancer pharmacologist Donald McDonnell of a new drug treatment has changed the lives of thousands of patients of a type of breast cancer. The decade-long research behind the drug is exemplary of the benefits of the historical partnership between the federal government and universities in supporting biomedical research. It also shows the singular role universities play in developing treatments that can be brought to market.

Dean Emerita Wilson’s gift will fund an international visiting professorship and Duke’s Center for Nursing Research, to be renamed in her honor.

Duke University start-up company VQ Biomedical is developing a minimally-invasive catheter-based oxygenator for patients whose heart or lungs are failing.

A proposed cap on National Institutes of Health funding could cost Duke University millions and stall critical breakthroughs -- like Laurie Sanders's blood test for early Parkinson's disease.

In a packed learning hall, Duke University School of Medicine celebrated Match Day 2025, when the next generation of doctors learned what awaits them after finishing medical school. The event marked the culmination of years of dedication and hard work, as 116 students discovered their residency destinations.

An artificial intelligence (AI) model developed by Duke Health researchers accurately predicted when adolescents were at high risk for future serious mental health issues before symptoms become severe.

Thanks to the support of R. Sanders “Sandy” Williams, MD'74, HS'77-'80, and family, a newly-established fund will provide support to laboratory-based research projects conducted by physician-scientists in the School of Medicine.

Albert Howell shares his journey to the MD program at Duke and the importance of scholarship support in making his dream come true.

Duke University School of Medicine’s research symposium showcased how discovery science, AI, technology, and translation are driving progress on some of the biggest challenges in biomedical science.